Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0003 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0003 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0009 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.0009 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |